Vitiligo Patient Population and Disease Burden in France: VIOLIN Study Results From the CONSTANCES Cohort.

Khaled Ezzedine Julien SeneschalAudrey Da SilvaNathalie PréaubertAnne LamblinCarine DelattreCorinne EmeryCamille NevoretJonathan FinziStéphane Bouée Thierry Passeron

Published in: Journal of the European Academy of Dermatology and Venereology : JEADV (2023)

Patients with vitiligo in France have high disease burden, particularly those with visible lesions or higher BSA involvement. Most patients are not receiving treatment, highlighting the need for new effective treatments and patient/physician education.

Keyphrases

end stage renal disease
case report
ejection fraction
newly diagnosed
healthcare
chronic kidney disease
primary care
prognostic factors
risk factors
patient reported outcomes
patient reported
smoking cessation